FDA Approved: METHYLERGONOVINE MALEATE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's generic methylergonovine maleate (ANDA 211455) for prevention of postpartum hemorrhage due to uterine atony after delivery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage
• Uterine Atony

Drugs mentioned

• METHYLERGONOVINE MALEATE (Methylergonovine maleate)

Snippet

ORIG AP for METHYLERGONOVINE MALEATE (METHYLERGONOVINE MALEATE)